LEADER 01000caa a22002652c 4500
001 NLM303967242
003 DE-627
005 20250226085706.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2019.108319  |2 doi 
028 5 2 |a pubmed25n1013.xml 
035 |a (DE-627)NLM303967242 
035 |a (NLM)31794865 
035 |a (PII)S1521-6616(19)30409-7 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Vecchione, Andrea  |e verfasserin  |4 aut 
245 1 0 |a Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 04.08.2020 
500 |a Date Revised 20.08.2020 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2019 Elsevier Inc. All rights reserved. 
520 |a Autoantibodies (AAbs) are a hallmark of Type 1 diabetes (T1D). Alterations in the frequency and phenotype of follicular helper (Tfh) T cells have been previously documented in patients with type 1 diabetes (T1D), but the contribution of follicular regulatory T (Treg) cells, which are responsible for suppressing AAb development, is less clear. Here, we investigated the frequency and activation status of follicular (CXCR5+) and conventional (CXCR5-) Treg cells in the blood of children with new-onset T1D, and children with risk for developing T1D (AAb-positive) and compared them to AAb-negative controls. Blood follicular and conventional Treg cells were higher in frequency in children with new onset T1D, but expressed reduced amounts of PD-1 as compared to AAb-negative children. Interestingly, the proportion of circulating FOXP3+ Tregs expressing PD-1 was also reduced in AAb-positive at-risk children as compared to AAb-negative controls, suggesting its potential use as a biomarker of disease progression. Follicular Treg cells were reduced in frequency in the spleens of prediabetic NOD mice as they became older and turned diabetic. Interestingly, PD-1 expression declined also on circulating follicular and conventional Treg cells in prediabetic NOD mice as they aged. Together, these findings show that the frequency of circulating follicular and conventional Treg cells and their levels of PD-1 change with disease progression in children at-risk for developing T1D and in NOD mice 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Extramural 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a AAb-negative 
650 4 |a AAb-positive 
650 4 |a Autoantibodies (AAb) 
650 4 |a CXCL13 
650 4 |a Follicular Treg cells 
650 4 |a PD-1 
650 4 |a Regulatory T cells (Treg) 
650 4 |a Tfh cells 
650 4 |a Type 1 diabetes (T1D) 
650 7 |a Autoantibodies  |2 NLM 
650 7 |a CXCR5 protein, human  |2 NLM 
650 7 |a FOXP3 protein, human  |2 NLM 
650 7 |a Forkhead Transcription Factors  |2 NLM 
650 7 |a PDCD1 protein, human  |2 NLM 
650 7 |a Programmed Cell Death 1 Receptor  |2 NLM 
650 7 |a Receptors, CXCR5  |2 NLM 
700 1 |a Di Fonte, Roberta  |e verfasserin  |4 aut 
700 1 |a Gerosa, Jolanda  |e verfasserin  |4 aut 
700 1 |a Jofra, Tatiana  |e verfasserin  |4 aut 
700 1 |a Cicalese, Maria Pia  |e verfasserin  |4 aut 
700 1 |a Napoleone, Vincenzo  |e verfasserin  |4 aut 
700 1 |a Ippolito, Elio  |e verfasserin  |4 aut 
700 1 |a Galvani, Giuseppe  |e verfasserin  |4 aut 
700 1 |a Ragogna, Francesca  |e verfasserin  |4 aut 
700 1 |a Stabilini, Angela  |e verfasserin  |4 aut 
700 1 |a Bianconi, Eleonora  |e verfasserin  |4 aut 
700 1 |a Grogan, Pauline  |e verfasserin  |4 aut 
700 1 |a Bonura, Clara  |e verfasserin  |4 aut 
700 1 |a Bonfanti, Riccardo  |e verfasserin  |4 aut 
700 1 |a Frontino, Giulio  |e verfasserin  |4 aut 
700 1 |a Nano, Rita  |e verfasserin  |4 aut 
700 1 |a Melzi, Raffaela  |e verfasserin  |4 aut 
700 1 |a De Pellegrin, Maurizio  |e verfasserin  |4 aut 
700 1 |a Laurenzi, Andrea  |e verfasserin  |4 aut 
700 1 |a Meschi, Franco  |e verfasserin  |4 aut 
700 1 |a Barera, Graziano  |e verfasserin  |4 aut 
700 1 |a Rigamonti, Andrea  |e verfasserin  |4 aut 
700 1 |a Indirli, Rita  |e verfasserin  |4 aut 
700 1 |a Bosi, Emanuele  |e verfasserin  |4 aut 
700 1 |a Piemonti, Lorenzo  |e verfasserin  |4 aut 
700 1 |a Aiuti, Alessandro  |e verfasserin  |4 aut 
700 1 |a Battaglia, Manuela  |e verfasserin  |4 aut 
700 1 |a Fousteri, Georgia  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 211(2020) vom: 01. Feb., Seite 108319  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnas 
773 1 8 |g volume:211  |g year:2020  |g day:01  |g month:02  |g pages:108319 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2019.108319  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 211  |j 2020  |b 01  |c 02  |h 108319